APM logo
APM NASDAQ GB

Aptorum Group Limited - Class A Ordinary Shares

Healthcare · Biotechnology Website · IPO Dec 2018
$0.93
▼ $-0.03 (-2.94%)
Vol 13K
5
Quality Score
fail
Mkt Cap
$8.6M
ROE
-19.5%
Margin
-1115.1%
D/E
14.73
Beta
-0.29
52W
$1–$7

Wall Street Consensus

6 analysts · Sep 2023
1
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
83.3%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -19.5% -19.5% -19.5% -19.5% -19.5%
P/E (TTM)
Net Margin -1115.1% -1115.1% -1115.1% -1115.1% -1115.1%
Gross Margin 7.1% 7.1% 7.1% 7.1% 7.1%
D/E Ratio 14.73 15.70 15.70 15.70 14.73 14.73
Current Ratio 2.98 0.22 0.22 0.22 2.98 2.98

Key Ratios

ROA (TTM)
-25.2%
P/S (TTM)
7.19
P/B
0.7
EPS (TTM)
$-0.79
CF/Share
$-2.89
52W High
$7.49
52W Low
$0.69
$0.69 52-Week Range $7.49

How does APM compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

APM valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
7.2
44% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.7
70% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

APM profitability vs Biotechnology peers

ROE
-19.5%
71% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-1115.1%
289% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
7.1%
91% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-25.2%
46% above peers (-46.7%)
vs Peers
vs Industry
Top tier

APM financial health vs Biotechnology peers

D/E ratio
14.7
0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
3.0
33% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
-0.3
129% below peers (1.0)
vs Peers
vs Industry
More volatile

APM fundamentals radar

APM Peer median Industry

APM profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

APM vs peers: key metrics

Latest News

No related news yet